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Exploring mutasynthesis to increase structural
diversity in the synthesis of highly oxygenated
polyketide lactones†
J. M. Botubol-Ares,a M. J. Durán-Peña,a A. J. Macías-Sánchez,a J. R. Hanson,b
I. G. Colladoa and R. Hernández-Galán*a
The enantioselective synthesis of (2R,3R,4E,8E)-3-hydroxy-2,4,8-trimethyldeca-4,8-dienolide (5) by
ring-closing metathesis is described. This compound is an analogue of 3,4-dihydroxy-2,4,6,8-tetra-
methyldec-8-enolide (4) which is a rare 11-membered lactone produced by the fungus, Botrytis cinerea.
Mutasynthetic studies with compound 5 using two mutants of B. cinerea led to the isolation of four new
highly oxygenated 11-membered lactones (11–14) in which compound 5 has been stereoselectively
epoxidized and hydroxylated at sites that were not easily accessible by classical synthetic chemistry.
Introduction
Botrytis cinerea is a grey powdery phytopathogenic mould that
affects a large number of commercial crops.1 Its major phyto-
toxic metabolites are a family of sesquiterpenes with the
botryane carbon skeleton2 and two groups of polyketides
exemplified, on the one hand, by the botcinic and botcineric
acids (1) and their cyclic derivatives, the botcinins (2),3 and on
the other hand, by botrylactone (3).4 A related lactone,
3,4-dihydroxy-2,4,6,8-tetramethyldec-8-enolide (4), has been
isolated5 from a mutant strain of B. cinerea. This lactone
possesses the same carbon chain as botrylactone with identical
functional groups and stereochemistry in the C1–C4 fragments
as both the botcinins and botrylactone. This structural hom-
ology and the presence of compound 4 in cultures of the
strains of B. cinerea which also produce large amounts of the
botcinins suggest that they have a common biosynthetic
origin. Compound 4 may be a ‘shunt’ metabolite in this
pathway (Fig. 1).
The sequencing of the B. cinerea genome led to the develop-
ment of genetically modified strains lacking the genes which
code for the enzymes that are involved in the biosynthesis of
the secondary metabolites produced by this fungus.6 Studies
of the metabolites produced by these mutants permitted the
identification of the genes involved in the production of the
polyketides.7 The genes responsible for the formation of the
per-methylated tetraketide core of both botcinins (2) and botry-
lactones (3) are all included in the same cluster comprising
genes BcBOA1 to BcBOA6. The latter encodes the polyketide
synthase (PKS).6
Naturally-occurring medium-sized lactones (8 to 11-mem-
bered lactones) are a relatively small number of metabolites
which have nevertheless attracted considerable attention
because of the range of biological activities which they
possess.8 In particular there are only a few examples of
11-membered lactones that are found in nature.9 Apart from
compound 4 and some complex pyrrolizidine and daphniphyl-
lum alkaloids, there are only reports of two insect phero-
mones, ferrulactone I10 and suspensolide,11 and four fungal
metabolites including the aspercyclides A–C.12 The latter have
anti-inflammatory activity and have potential to be used in the
treatment of allergic disorders such as asthma.
Fig. 1 Some polyketides produced by B. cinerea.
†Electronic supplementary information (ESI) available: Copies of the 1H NMR
and 13C NMR spectra for all key intermediates and final products, 2D NMR of
11–14 as well as nOe spectra of (E)-5 and 11–14. See DOI: 10.1039/c4ob00717d
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The relative thermodynamic instability of 11-membered lac-
tones has made their synthesis and that of their derivatives
difficult even using Mitsunobu lactonization13 or an intramole-
cular Reformatsky reaction.14 Recently, ring-closing metathesis
(RCM) has been developed to provide an efficient method for
the preparation of some 11-membered lactones from acyclic
precursors.15 However RCM reactions in the macrocyclic series
tend to give mixtures of the (E) and (Z) isomers of cyclic
olefins. A reliable general method for controlling the geometry
of the new double bond is yet to be found.16 Consequently
there are few examples of synthetic analogues whose biological
activity has been thoroughly evaluated. Although botrylactone
was described by Welmar et al.17 as a powerful antibiotic
whilst the botcinins have been reported18 to show antifungal
activity against Magnaporthe grisea, the causal agent of rice
blast, nothing is known of the biological activity of compound
4 or its close relatives because of the small amount of material
that has been isolated.
Mutasynthesis is a very interesting strategy that combines
chemical synthesis with biosynthetically-patterned biotrans-
formations using genetically engineered microorganisms.19
The availability of mutants of B. cinerea blocked in the early
stages of the pathway but retaining some of the later stages
leading to these 11-membered lactones has allowed us to
explore the use of mutasynthesis to generate modified
11-membered lactones that are analogues of compound 4 in
order to evaluate their biological activity.
Results and discussion
We chose compound 5 as a simplified analogue of compound
4 although the stereochemistry of the alcohol at C-3 is
different. However it could be easily synthesized in sufficient
quantity for the mutasynthesis experiments. The retrosynthetic
analysis of the lactone is shown in Scheme 1. An RCM cycliza-
tion of the ester 6 and a syn aldol reaction of the aldehyde 7
play key roles in the stereoselective construction of the
11-membered lactone ring.
The synthetic sequence leading to the lactone 5 is shown in
Scheme 2. 2-Methyl-2-vinyloxirane was treated with commer-
cially available 2-methylallyl magnesium chloride in the pres-
ence of CuI to produce the allylic alcohol 8 in a yield of 95%.20
Oxidation of 8 with TEMPO-BAIB (2,2,6,6-tetramethyl piperidi-
nyloxy-bis(acetoxy)iodobenzene)21 afforded the aldehyde 7.
This was then treated with the boron Z-enolate of the N-propio-
nyl oxazolidinone (−)-(R)-922 to give the syn-aldol product 10 in
70% yield and 88% de.‡ Exocyclic cleavage of the oxazolidi-
none 10 with allyl alcohol and 4 eq. of allylmagnesium
bromide at −20 °C generated the ester 6 with a yield of 67%.
Finally an RCM reaction of 6 under high dilution conditions
catalysed by the second-generation ruthenium complex A23
in dry, degassed, refluxing dichloromethane produced the
11-membered lactone 5 with a good regioselectivity and yield
(9 : 1 E/Z ratio, 68% yield).§‡ This is in agreement with mole-
cular mechanics calculations (MM2) which predict that the
(E)-alkene is the most stable regioisomer.24
The lactone 5 was then incubated with two mutant strains
of B. cinerea, bcbot2Δ and bcboa6Δbcbot2Δ (bcΔΔd1). The first
mutant, which was obtained by deactivating the botryane bio-
synthesis gene BcBOT2 that encodes a sesquiterpene cyclase,25
does not produce the botryanes but does produce a significant
amount of botcinic acid (1a) and its relatives. The second
mutant, bcΔΔd1,6 is a double mutant which was obtained by
deactivating the genes BcBOT2 and BcBOA6 and is conse-
quently unable to produce the three characteristic families of
metabolites: the botryanes, the botcinins and the botry-
lactone.6 Incubation of compound 5 with both mutant strains
using liquid surface-culture conditions gave four new 11-mem-
bered lactones 11–14 (Fig. 2). Their distribution and % yields
are shown in Table 1. The strain bcbot2Δ gave a higher conver-
sion of compound 5. The metabolites 11, 12 and 13 were
Scheme 1 Retrosynthetic analysis of lactone 5.
Scheme 2 Stereoselective synthesis of 5.
‡Ratio valuated using 1H-NMR.
§ It is noteworthy that with the first-generation ruthenium catalyst
PhCHvRuCl2(PCy3)2, a linear dimer was obtained after 16 h at reflux in CH2Cl2.
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produced in both cases but there was no apparent incorpor-
ation of compound 5 into the botcinin/botrylactone pathway.
The structures of the metabolites were established from their
1H and 13C NMR spectra using a combination of 1D and 2D
NMR experiments (see ESI†).
Compound 11 was obtained as a colourless oil whose
HRMS possessed a molecular ion at m/z 240.1353 corres-
ponding to the molecular formula C13H20O4. The
13C NMR
spectrum contained resonances at δC 81.6, 62.9, 59.8 and
58.6 ppm (CH, CH2, C, and CH carbons respectively) and at
δC 174.4 ppm (C carbon) consistent with the presence of four
C–O and one lactone CvO carbon atoms in the molecule. The
main difference between the 1H NMR spectra of compounds 5
and 11 was the absence of the olefinic proton H-9 and the
appearance of a double-doublet ( J 10.0 and 4.2 Hz) at
δH 3.01 ppm in compound 11. The presence of an epoxide at
this position was confirmed by an HSQC correlation of H-9
with the signal at δC 58.6 ppm (C-9) and HMBC correlations
between H-9 and signals at δC 59.8 (C-8) and δC 62.9 ppm
(C-10). The stereochemistry of the oxirane ring was established
by nOe experiments which were rationalized on the basis of
the lowest energy optimized conformer derived from MM2 cal-
culations (Fig. 3).24 In particular there were interactions
between H-9 and δH 5.17 (H-5), δH 2.16–2.08 (H-6β), and
δH 1.08 (H-7β) and between the signals at δH 1.75 (4-Me) and
δH 1.31 (8-Me). There were also nOe effects involving the signals
at δH 3.99 (H-3β) and δH 1.28 (2-Meβ). These were consistent
with the epoxidation of compound 5 on the β-face of the
ring.26 Based on the known absolute configuration of com-
pound 5 and the MM2 calculations, compound 11 has the
absolute configuration (2R,3R,4E,8S,9S).
The HRMS (m/z 239.1282, M − H+) of compound 12
was consistent with the molecular formula C13H20O4.
The 13C NMR spectrum contained 13 signals. A comparison
with compound 5 showed that the resonance for C-7 [δC 38.2 (t)]
had changed to δC 77.2 (d) in compound 12. There were COSY
correlations between δH 4.18 (H-7) and the signals at δH 2.46
and 2.30 which were assigned to H-6α and H-6β respectively.
There were nOe effects which were observed (Fig. 3)
between the signals at δH 4.18 (H-7), 5.62 (H-9), 5.02 (H-5) and
H-6β, together with δH 4.70 (H-10β) and H-9. These were con-
sistent with the R configuration at C-7 and hence compound
12 was (2R,3R,4E,7R,8E)-3,7-dihydroxy-2,4,8-trimethyldeca-4,8-
dienolide.
The HRMS data for compounds 13 and 14 showed that they
both had a molecular formula, C13H20O5. Their
13C NMR
spectra contained five C–O signals at δC 81.4 (CH, C-3), 76.9
(CH, C-7), 62.6 (C, C-8), 62.2 (CH2, C-10) and 56.6 (CH, C-9)
ppm for compound 13 and δC 80.9 (CH, C-3), 65.9 (CH, C-6),
62.8 (CH2, C-10), 58.6 (CH, C-9) and 58.0 (C, C-8) ppm for 14.
These compounds possessed similar 1H NMR spectra in which
the olefinic C–H of compound 5 had been replaced by epoxy
C–H signals at δH 3.09 (dd, J 10.0, 4.0 Hz) and δH 3.05 (dd, J
10.2, 4.2 Hz) respectively. However compound 13 possessed a
new CH(OH) signal at δH 3.22 (dd, J 11.3, 5.2 Hz) (H-7) which
showed COSY correlations with signals at δH 2.50 (H-6α) and
δH 2.32 (H-6β). Compound 14 possessed a new CH(OH) signal
at δH 4.64 (triplet J 11.2 of doublets J 4.8 Hz) (H-6) which
showed COSY correlations with signals at δH, 2.48 (H-7β),
δH 1.12 (H-7α) and 5.20 (H-5). The nOe effects, shown in Fig. 3,
were in accord with the optimized structures obtained by MM2
calculations24 and, bearing in mind the origin of the metab-
olites, led to the absolute stereochemistry for compounds 13
and 14 as 2R,3R,4E,7R,8S,9S and 2R,3R,4E,6R,8S,9S respectively.
Fig. 2 Metabolites isolated in mutasynthesis.
Table 1 Distribution and yields of isolated metabolites
Strains Metabolites (% yields)
bcbot2Δ 5 (3), 11 (5), 12 (4), 13 (19), 14 (1)
bcΔΔd1 5 (23), 11 (15), 12 (7), 13 (7)
Fig. 3 MM2 minimized models with decisive nOe correlations for com-
pounds 11–14.
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These mutasynthetic transformations have produced deriva-
tives that were hydroxylated at C-6 and C-7 and regioselectively
epoxidized at C-8/C9. However there was no hydration of epoxi-
dation of the C4/C5 double bond. Consequently additional
synthetic work is necessary in order to develop an efficient
route for the synthesis of closer analogues of compound 4.
Compounds 11 and 13 did not show any significant
anti-bacterial activity at a concentration of 200 ppm against
Escherichia coli, Bacillus subtilis or Streptococcus faecalis.27
Compounds 11 and 13 did not show any significant phytotoxic
activity when tested in vivo on sterilized leaves of Phaseolus
vulgaris at a concentration of 500 ppm.28
Conclusions
The regioselective ring-closing metathesis of the triene 6 has
provided an efficient method for the asymmetric synthesis of
(2R,3R,4E,8E)-3-hydroxy-2,4,8-trimethyldeca-4,8-dienolide (E)-5
in 5 steps with 26% overall yield from simple starting
materials. This compound is an advanced analogue of 3,4-
dihydroxy-2,4,6,8-tetramethyldec-8-enolide (4) which is a
scarce metabolite of B. cinerea. Compound 5 was biotrans-
formed by two mutant strains of B. cinerea, bcbot2Δ and
bcΔΔd1, into four new highly oxygenated 11-membered lac-
tones. These mutasynthetic steps involved regioselective epoxi-
dation of the C8/C9 double bond and hydroxylation at either
the C-6 (minor) or C-7 (major) positions. This has proved to be
a valuable and versatile approach to increasing the structural
diversity of 11-membered lactones. Further experiments are in
progress to develop a synthesis method of compound 4.
Experimental
General procedures
Unless otherwise noted, materials and reagents were obtained
from commercial suppliers and were used without further
purification. Dichloromethane was freshly distilled from CaH2
and tetrahydrofuran was dried over sodium and benzophe-
none and freshly distilled before use. Air- and moisture-sensi-
tive reactions were performed under an argon atmosphere.
Purification by semipreparative and analytical HPLC was per-
formed with a Hitachi/Merck L-6270 apparatus equipped with
a differential refractometer detector (RI-7490). A LiChrospher®
Si 60 (5 µm) LiChroCart® (250 mm × 4 mm) column and a
LiChrospher® Si 60 (10 µm) LiChroCart® (250 mm × 10 mm)
column were used in isolation experiments. Silica gel (Merck)
was used for column chromatography. TLC was performed
on a Merck Kiesegel 60 F254, 0.25 mm thick. Melting points
were measured with a Reichert-Jung Kofler block and are
uncorrected. Optical rotations were determined with a digital
polarimeter. Infrared spectra were recorded on a FT-IR spectro-
photometer and reported as wave number (cm−1). 1H and
13C NMR measurements were recorded on Varian Unity 400 MHz,
Agilent 500 MHz and Varian Inova 600 MHz spectrometers
with SiMe4 as the internal reference at room temperature.
J values are given in Hz. Chemical shifts were referenced to
CDCl3 (δH 7.25, δC 77.0). NMR assignments were made using a
combination of 1D and 2D techniques. Multiplicities are
described using the following abbreviations: s = singlet, d =
doublet, t = triplet, q = quarter; quint = quintuplet; sext =
sextuplet; m = multiplet, br = broad. High-Resolution Mass
Spectroscopy (HRMS) was recorded with a double-focusing
magnetic sector mass spectrometer in positive ion mode or
with a QTOF mass spectrometer in positive ion electrospray
mode at 20 V cone voltage. HRESIMS/MS experiments were
performed with a QTOF mass spectrometer at 20 V cone
voltage and 10 eV collision energy.
Microorganisms
B. cinerea mutants, bcbot2Δ and bcΔΔd1, were previously
obtained by deactivating the genes encoding the sesquiterpene
synthase BcBOT2,25 the synthase BcBOT2 and the polyketide
synthase BcBOA6,6 respectively, and are maintained in the
BIOGER strain collection INRA (Grignon, France). Conidial
stock suspensions of these strains were maintained in glycerol
(80%) at −40 °C.
Synthesis of the substrates
(E)-2,6-Dimethylhepta-2,6-dien-1-ol (8). 2-Methylallylmagne-
sium chloride (58.4 mL of a 0.5 M solution in THF,
29.2 mmol) at −30 °C was added to a stirred solution of
2-methyl-2-vinyloxirane (2 mL, 20.9 mmol) and CuI (199 mg,
1.04 mmol) in dry THF (22 mL) at −30 °C. The mixture was
stirred at −30 °C and, after 3 h, was treated with a saturated
ammonium chloride solution (60 mL) and then allowed to
warm to room temperature. The aqueous layer was extracted
three times with diethyl ether (90 mL). Combined extracts were
washed with 1 N HCl (200 mL), saturated sodium bicarbonate
(200 mL), water (200 mL), and brine (200 mL) and then dried
over anhydrous sodium sulphate. Finally, the solvent was con-
centrated under reduced pressure and the crude was purified
by silica gel column chromatography eluted with pentane–
Et2O (80 : 20) to yield compound 8 (2756 mg, 94%) as a colour-
less oil. Spectroscopic data of compound 8 were identical to
those described in the literature.20
(E)-2,6-Dimethylhepta-2,6-dienal (7). TEMPO (890 mg,
5.6 mmol) and (diacetoxyiodo)benzene (BAIB, 18.3 g,
83.7 mmol) were added at 0 °C to a solution of (E)-2,6-
dimethylhepta-2,6-dien-1-ol (8) (3.9 g, 27.9 mmol) in dry
CH2Cl2 (62 mL). The mixture was stirred for 6 h and the
solvent was concentrated under reduced pressure. The crude
was purified by silica gel column chromatography eluted with
pentane–Et2O (96 : 4) to yield the aldehyde 7 (3339 mg, 87%)
as a yellow oil. IR (film) νmax/cm
−1 2925, 2852, 2769 (CHO),
1702 (CO), 1420, 1102, 1090; 1H NMR (400 MHz, CDCl3)
δH 1.71 (6H, s, 2-Me, 6-Me), 2.20 (2H, t, J 7.2, 5-H), 2.49 (2H, dq,
J 7.2, 0.6, 4-H), 4.70 (1H, br s, 7a-H), 4.77 (1H, br s, 7b-H), 6.47
(1H, tq, J 7.2, 1.0, 3-H), 9.38 (1H, s, 1-H); 13C NMR (100 MHz,
CDCl3) δC 9.1 (q, 2-Me), 22.2 (q, 6-Me), 26.8 (t, C4), 36.0 (t, C5),
110.8 (t, C7), 139.3 (s, C2), 143.9 (s, C6), 153.9 (d, C3), 195.0
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4,8-dienoyl]-oxazolidin-2-one (10). n-Dibutylboron triflate
(5.2 mL of a 1.0 M solution in CH2Cl2, 5.2 mmol) was added
dropwise at 0 °C to a stirred solution of (−)-(4R)-4-benzyl-3-pro-
pionyloxazolidin-2-one ((−)-(R)-9) (1020 m, 4.36 mmol) in dry
CH2Cl2 (6.3 mL) under argon atmosphere conditions. The
mixture was stirred for 5 min and then N,N′-diisopropylethyla-
mine was added dropwise (0.96 mL, 5.7 mmol). After complete
addition, the mixture was stirred at 0 °C for 15 min. The yellow
solution was re-cooled to −78 °C and a solution of (E)-2,6-
dimethylhepta-2,6-dienal (7) (1220 mg, 8.71 mmol) was added
dropwise in dry CH2Cl2 (2.0 mL). The mixture was stirred at
−78 °C and was then allowed to warm to 0 °C and stirred for
an additional hour. The reaction was quenched with a mixture
of phosphate buffer (5 mL of a 1.0 M solution at pH 7) and
MeOH (15 mL) at 0 °C and the mixture was stirred for 5 min.
Finally, a solution of 2.4 : 1 MeOH–H2O2 (30%, 15 mL) was
added slowly at 0 °C and stirred for an additional hour. The
solvent was concentrated under reduced pressure and the
residue was re-dissolved in diethyl ether. The aqueous layer
was extracted three times with diethyl ether (35 mL). Com-
bined extracts were washed with brine (200 mL), dried over
anhydrous sodium sulphate, filtered, the solvent evaporated
and the crude was purified by silica gel column chromato-
graphy eluted with petroleum ether–ethyl acetate (75 : 25) to
yield compound 10 (1126 mg, 70%) as a white solid. m.
p. 37 °C (from CH2Cl2); [α]
20
D −41.3° (c 0.65 in CHCl3); IR (film)
νmax/cm
−1 3524 (OH), 3176, 2935, 1781 (CO), 1698 (CO), 1456,
1385, 1208, 1107, 886, 747; 1H NMR (400 MHz, CDCl3) δH 1.16
(3H, d, J 6.8, 2′-Me), 1.60 (3H, s, 4′-Me), 1.70 (3H, s, 8′-Me),
2.05 (2H, t, J 7.4, 7′-H), 2.18 (2H, q, J 7.4, 6′-H), 2.77 (1H, dd,
J 13.4, 9.2, CHHPh), 2.88 (d, J 2.8, 3′-OH), 3.24 (1H, dd, J 13.4,
3.2, CHHPh), 3.95 (1H, dq, J 6.8, 3.6, 2′-H), 4.18 (2H, m, 5a-H,
5b-H), 4.33 (1H, br s, 3′-H), 4.64–4.66 (2H, m, 4-H, 9′a-H), 4.69
(1H, br s, 9′b-H), 5.52 (1H, t, J 7.4, 5′-H), 7.17–7.33 (5H, m,
Harom); 13C NMR (100 MHz, CDCl3) δC 10.4 (q, 2′-Me), 13.3 (q,
4′-Me), 22.3 (q, 8′-Me), 25.7 (t, C6′), 37.4 (t, C7′), 37.6 (t,
CH2Ph), 40.4 (d, C2′), 55.2 (d, C4), 66.0 (t, C5), 75.1 (d, C3′),
109.9 (t, C9′), 125.7 (d, C5′), 127.3 (Carom), 128.8 (2C, Carom),
129.3 (2C, Carom), 133.6 (s, C4′), 135.0 (s, Carom), 145.3 (s,
C8′), 152.9 (s, C2), 176.9 (s, C1′); HRMS (CI+): calcd for
C22H29NO4 [M]
+ 371.2097, found 371.2088.
(2R,3R,4E)-Allyl 3-hydroxy-2,4,8-trimethylnona-4,8-dienoate
(6). Allylmagnesium bromide (4.9 mL of a 1.0 M solution in
Et2O, 4.9 mmol) was added at 0 °C to alcohol (15 mL) under
argon conditions in a Schlenk flask. The allylic mixture was
stirred for 10 min and re-cooled at −20 °C. Then, a solution of
10 (886 mg, 2.40 mmol) in allylic alcohol (3 mL) was slowly
added. When TLC monitoring indicated the completion of the
reaction (3 h), a saturated ammonium chloride solution
(20 mL) was added and then allowed to warm to room temp-
erature. The aqueous layer was extracted three times with
diethyl ether (50 mL). Combined extracts were washed with
brine (100 mL), dried over anhydrous sodium sulphate, filtered
and the solvent was concentrated under reduced pressure. The
crude product was purified by silica gel column chromato-
graphy eluted with petroleum ether–Et2O (90 : 10) to yield the
ester 6 (405 mg, 67%) as a yellow oil. [α]20D +3.7° (c 0.42 in
CHCl3); IR (film) νmax/cm
−1 3448 (OH), 2924, 1736 (CO), 1458,
1376, 1170, 1032, 888; 1H NMR (400 MHz, CDCl3) δH 1.15 (3H,
d, J 7.1, 2-Me), 1.60 (3H, s, 4-Me), 1.71 (3H, s, 8-Me), 2.04 (2H,
t, J 7.6, 7-H), 2.13–2.20 (2H, m, 6-H), 2.25 (d, J 4.4, 3-OH), 2.70
(1H, dq, J 7.1, 4.4, 2-H), 4.27 (1H, t, J 4.4, 3-H), 4.57 (2H, dt,
J 5.6, 1.4, 1′-H), 4.66 (1H, br s, 9b-H), 4.70 (1H, br s, 9a-H), 5.23
(1H, ddd, J 10.4, 2.8, 1.4, 3′b-H), 5.31 (1H, ddd, J 17.4, 2.8, 1.4,
3′a-H), 5.47 (1H, t, J 7.0, 5-H), 5.90 (1H, ddt, J 17.4, 10.4, 5.6,
2′-H); 13C NMR (100 MHz, CDCl3) δC 11.3 (q, 2-Me), 12.7 (q,
4-Me), 22.5 (q, 8-Me), 25.8 (t, C6), 37.4 (t, C7), 43.0 (d, C2), 65.2
(t, C1′), 76.8 (d, C3), 110.0 (t, C9), 118.3 (t, C3′), 126.6 (d, C5),
132.0 (d, C2′), 134.0 (s, C4), 145.4 (s, C8), 175.1 (s, C1); HRMS
(CI+): calcd for C15H24O3 [M]
+ 252.1725, found 252.1718.
RCM of 6. (1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinyli-
dene)dichloro( phenylmethylene)(tricyclohexyl-phosphine)
ruthenium (Grubbs ruthenium catalyst A, 121.3 mg,
0.14 mmol) was added to a refluxed and stirred solution of
ester 6 (180.0 mg, 0.71 mmol) in degassed and dry CH2Cl2
(420 mL) under argon conditions. The reaction mixture was
stirred until consumption of the starting material (20 h). The
crude was filtered over a pad of silica gel and washed with
ethyl acetate (400 mL). The solvent was removed under
reduced pressure to give a crude that was purified by silica gel
column chromatography eluted with ether petroleum–ethyl
acetate (90 : 10). Final purification was carried out by semi-pre-
parative HPLC (ether petroleum–ethyl acetate 85 : 15; flow =
3.0 mL min−1) to yield a mixture 9 : 1 of (E)-5 (108.6 mg, 68%)
and (Z)-5.¶
(2R,3R,4E,8E)-3-Hydroxy-2,4,8-trimethyldeca-4,8-dienolide
((E)-5). Colourless oil; tR = 28 min; [α]
20
D +116° (c 0.42 in
CHCl3); IR (film) νmax/cm
−1 3442 (OH), 2918, 2850, 1731 (CO),
1455, 1374, 1259, 1164, 1024, 904, 794; 1H NMR (500 MHz,
CDCl3) δH 1.25 (3H, d, J 6.5, 2-Me), 1.61 (3H, s, 4-Me), 1.71 (3H,
s, 8-Me), 1.94–2.02 (1H, m, 7b-H), 2.02–2.11 (1H, m, 6b-H),
2.13–2.19 (1H, dt, J 11.6, 4.0, 7a-H), 2.41 (1H, dq, J 12.2, 4.0,
6a-H), 2.64 (1H, dq, J 10.0, 6.5, 2-H), 3.93 (1H, d, J 10.0, 3-H),
4.33 (1H, t, J 10.6, 10b-H), 4.68 (1H, dd, J 10.6, 6.2, 10a-H), 5.02
(1H, dd, J 11.7, 4.0, 5-H), 5.50 (1H, m, 9-H); 13C NMR
(125 MHz, CDCl3) δC 10.2 (q, 4-Me), 13.8 (q, 2-Me), 15.6 (q,
8-Me), 25.7 (t, C6), 38.2 (t, C7), 44.8 (d, C2), 60.9 (t, C10), 82.2
(d, C3), 122.2 (d, C9), 127.9 (d, C5), 136.4 (s, C4), 143.6 (s, C8),




General methods. B. cinerea was grown on a surface culture
in Roux bottles on a Czapek-Dox medium (150 mL per flask)
comprising (per L of distilled water) glucose (50.0 g), yeast
extract (1.0 g), KH2PO4 (5.0 g), NaNO3 (2.0 g), MgSO4·7H2O
¶ (Z)-5 could not be purified.
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(0.5 g), and FeSO4·7H2O. The pH of the medium was adjusted
to 7.0 with aqueous NaOH (4 M). Each Roux bottle was inocu-
lated with 2 × 106 fresh conidia or six uniform discs of 0.9 cm
diameter mycelia of four-day old culture on malta agar. A
filter-sterilised aqueous solution of the labeled precursor or a
solution of (E)-5 in ethanol was fed at a carefully determined
optimum time. Roux bottles were incubated at 25 ± 2 °C in
daylight under static conditions for the optimum period of
time. The culture medium and mycelia were then separated by
filtration. The broth was separated with NaCl and extracted
with ethyl acetate (3×) and dried over anhydrous Na2SO4. The
organic extract obtained was evaporated under reduced
pressure to dryness.
Feeding of (2R,3R,4E,8E)-3-hydroxy-2,4,8-trimethyldeca-4,8-
dienolide ((E)-5) to B. cinerea bcbot2Δ and bcΔΔd1. Com-
pound (E)-5 (120 mg), dissolved in EtOH (960 µL), was distribu-
ted among 6 Roux bottles containing a 4-day old culture of
B. cinerea bcbot2Δ or bcΔΔd1 and grown for a further 6 days.
Filtration, ethyl acetate extraction and column chromatography,
followed by analytical HPLC purification, gave 11, 12, 13 and
14 in the yields shown in Table 1.
(2R,3R,4E,8S,9S)-8,9-Epoxy-3-hydroxy-2,4,8-trimethyldec-4-
enolide (11). Colourless oil; tR = 27 min, petroleum ether–
ethyl acetate (77 : 23), flow = 0.8 mL min−1; [α]20D +184° (c 0.34
in CHCl3); IR (film) νmax/cm
−1 3448 (OH), 1734 (CO), 1458,
1165, 1022, 887, 764; 1H NMR (400 MHz, CDCl3) δH 1.08 (3H,
dt, J 13.4, 4.8, 7b-H), 1.28 (3H, d, J 6.6, 2-Me), 1.31 (3H, s, 8-
Me), 1.75 (3H, t, J 1.6, 4-Me), 2.08–2.16 (2H, m, 6b-H, 7a-H),
2.37–2.48 (1H, m, 6a-H), 2.72 (1H, dq, J 10.0, 6.6, 2-H), 3.01
(1H, dd, J 10.0, 4.2, 9-H), 3.53 (1H, dd, J 10.8, 10.0, 10b-H),
3.99 (1H, dd, J 10.0, 1.8, 3-H), 4.86 (1H, dd, J 10.8, 4.2, 10a-H),
5.17 (1H, ddd, J 12.0, 3.2, 1.6, 5-H); 13C NMR (100 MHz,
CDCl3) δC 10.3 (q, 4-Me), 13.6 (q, 2-Me), 15.9 (q, 8-Me), 24.3 (t,
C6), 37.0 (t, C7), 43.6 (d, C2), 58.6 (d, C9), 59.8 (s, C8), 62.9 (t,
C10), 81.6 (d, C3), 126.9 (d, C5), 136.2 (s, C4), 174.4 (s, C1);




nolide (12). Colourless oil; tR = 28 min, petroleum ether–ethyl
acetate (53 : 47), flow = 0.8 mL min−1; [α]20D +219° (c 0.31 in
CHCl3); IR (film) νmax/cm
−1 3395 (OH), 2923, 1707 (CO), 1458,
1354, 1258, 1168, 1021, 935, 851, 750; 1H NMR (400 MHz,
CDCl3) δH 1.24 (3H, d, J 6.6, 2-Me), 1.64 (3H, t, J 1.2, 4-Me),
1.75 (3H, d, J 1.2, 8-Me), 2.25–2.32 (1H, m, 6b-H), 2.46 (1H,
ddd, J 13.6, 12.0, 11.2, 6a-H), 2.61 (1H, dq, J 10.2, 6.6, 2-H),
3.90 (1H, d, J 10.2, 3-H), 4.18 (1H, dd, J 11.2, 5.6, 7-H), 4.37
(1H, t, J 10.2, 10b-H), 4.70 (1H, dd, J 10.2, 6.0, 10a-H), 5.02
(1H, dd, J 12.0, 2.4, 5-H), 5.62 (1H, dd, J 10.2, 6.0, 9-H);
13C NMR (100 MHz, CDCl3) δC 10.1 (q, C8), 10.2 (q, C4), 13.8
(q, C2), 34.5 (t, C6), 44.0 (d, C2), 60.1 (t, C10), 77.2 (d, C7), 81.9
(d, C3), 121.2 (d, C9), 124.7 (d, C5), 137.3 (s, C4), 145.2 (s, C8),
174.8 (s, C1); HRMS (CI+): calcd for C13H19O4 [M − H]+
239.1283, found 239.1283.
(2R,3R,4E,7R,8S,9S)-8,9-Epoxy-3,7-dihydroxy-2,4,8-trimethyl-
dec-4-enolide (13). Colourless oil; tR = 31 min, petroleum
ether–ethyl acetate (53 : 47), flow = 0.8 mL min−1; [α]20D +94.1°
(c 0.47 in CHCl3); IR (film) νmax/cm
−1 3431 (OH), 2922, 2855
(CH), 1716 (CO), 1448, 1373, 1254, 1166, 1019, 848, 741;
1H NMR (400 MHz, CDCl3) δH 1.28 (3H, d, J 6.8, 2-Me), 1.34
(3H, s, 8-Me), 1.77 (3H, d, J 1.6, 4-Me), 2.28–2.35 (1H, m, 6b-H),
2.50 (1H, dt, J 13.6, 11.8, 6a-H), 2.69 (1H, dq, J 9.8, 6.8, 2-H), 3.09
(1H, dd, J 10.0, 4.0, 9-H), 3.22 (1H, dd, J 11.8, 5.2, 7-H), 3.56
(1H, dd, J 10.8, 10.0, 10b-H), 3.97 (1H, d, J 9.8, 3-H), 4.89 (1H,
dd, J 10.8, 4.0, 10a-H), 5.12 (1H, dd, J 11.8, 3.2, 5-H); 13C NMR
(100 MHz, CDCl3) δC 10.2 (q, 8-Me), 10.5 (q, 4-Me), 13.6 (q,
2-Me), 32.5 (t, C6), 43.4 (d, C2), 56.6 (d, C9), 62.2 (t, C10), 62.6
(s, C8), 76.9 (d, C7), 81.4 (d, C3), 122.5 (d, C5), 137.6 (s, C4), 174.4




dec-4-enolide (14). Colourless oil; tR = 38 min, petroleum
ether–ethyl acetate (30 : 70), flow = 0.8 mL min−1; [α]20D +46.3°
(c 0.11 in CHCl3); IR (film) νmax/cm
−1 3422 (OH), 2921, 2856
(CH), 1719 (CO), 1458, 1387, 1259, 1172, 1028, 932, 824; 1H
NMR (600 MHz, CDCl3) δH 1.12 (1H, t, J 11.2, 7b-H), 1.30 (3H,
d, J 6.6, 2-Me), 1.32 (3H, s, 8-Me), 1.83 (3H, d, J 1.2, 4-Me), 2.48
(1H, dd, J 11.2, 4.8, 7a-H), 2.72 (1H, dq, J 10.2, 6.6, 2-H), 3.05
(1H, dd, J 10.2, 4.2, 9-H), 3.49 (1H, dd, J 10.8, 10.2, 10b-H),
4.00 (1H, dd, J 10.2, 1.2, 3-H), 4.64 (1H, dt, J 11.2, 4.8, 6-H),
4.90 (1H, dd, J 10.8, 4.2, 10a-H), 5.20 (1H, d, J 11.2, 5-H); 13C
NMR (150 MHz, CDCl3) δC 10.7 (q, 4-Me), 13.5 (q, 2-Me), 17.1
(q, 8-Me), 43.7 (t, C7), 45.6 (d, C2), 58.0 (s, C8), 58.6 (d, C9),
62.8 (t, C10), 65.9 (d, C6), 80.9 (d, C3), 129.4 (d, C5), 139.0 (s,
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